Opus Genetics, Inc. · NASDAQ:IRD
Gagnon Robert E. sold 28,000 Opus Genetics, Inc. shares (Form 4)
Traded Sep 3, 2026 · Filed Sep 8, 2026
On Sep 3, 2026, Gagnon Robert E. (Chief Financial Officer) sold 28,000 Opus Genetics, Inc. shares at US$4.54 for US$127K, leaving 556,375 shares. Filed Sep 8, 2026 (Form 4).
- Sold
- 28,000 shares
- Price
- US$4.54
- Value
- US$127K
- Holding after
- 556,375 shares
- Trading plan
- No
- Role
- Chief Financial Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Sep 3, 2026 | Common Stock | Sale | 28,000 | US$4.54 | 556,375 | Direct |
Source
Related
- Opus Genetics, Inc.
- Gagnon Robert E.
- Opus Genetics, Inc. shareholders
- Form 4 · Gagnon Robert E. · Jul 27, 2026
- Form 4 · Gagnon Robert E. · Apr 27, 2026
- Form 4 · Foundation Fighting Blindness Retinal Degeneration Fund · Oct 2, 2026
- Form 4 · Magrath George · Sep 11, 2026
- Form 4 · Gallagher Cam · Sep 8, 2026
- Schedule 13G/A · Balyasny Asset Management L.P. · Aug 14, 2026
- Schedule 13G/A · Perceptive Advisors LLC · Aug 14, 2026